The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 348:2579-2580 June 19, 2003 Number 25
NextNext

The Chromogranin–Secretogranin Family

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Taupenot, L.
-PubMed Citation
To the Editor: Taupenot et al. (March 20 issue)1 state in their review article that the prognostic value of chromogranin A immunoreactivity in colorectal cancer has not been established. In fact, four out of five studies identify extensive neuroendocrine differentiation as an independent prognostic factor in Dukes' stage C colorectal cancer.2,3,4 Neuroendocrine differentiation also predicts a more aggressive clinical course in undifferentiated small-cell colorectal cancer.5


Hans Scherübl, M.D.
Patricia Grabowski, M.D.
Benjamin Franklin University Hospital
D-12200 Berlin, Germany
hans.scheruebl@medizin.fu-berlin.de

  1. Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogranin family. N Engl J Med 2003;348:1134-1149. [Free Full Text]
  2. Hamada Y, Oishi A, Shoji T, et al. Endocrine cells and prognosis in patients with colorectal carcinoma. Cancer 1992;69:2641-2646. [CrossRef][Web of Science][Medline]
  3. de Bruine AP, Wiggers T, Beek C, et al. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance. Int J Cancer 1993;54:765-771. [Web of Science][Medline]
  4. Grabowski P, Schindler I, Anagnostopoulos I, et al. Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer. Eur J Gastroenterol Hepatol 2001;13:405-411. [CrossRef][Web of Science][Medline]
  5. Grabowski P, Schonfelder J, Ahnert-Hilger G, et al. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum. Virchows Arch 2002;441:256-263. [CrossRef][Web of Science][Medline]
 
To the Editor: Taupenot et al. mention the accumulation of chromogranin A in the preamyloid plaques of Alzheimer's disease and its . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.